- Hydrocephalus, a neurological condition characterized by excessive accumulation of cerebrospinal fluid (CSF) in the brain, is witnessing increasing attention globally due to its prevalence in both pediatric and adult populations. The market is being driven by the growing availability of advanced treatment options, including programmable shunt systems and minimally invasive endoscopic third ventriculostomy (ETV), offering patients improved long-term outcomes and quality of life
- The escalating demand for hydrocephalus treatments is primarily fueled by increased awareness, early diagnostic initiatives, and supportive healthcare policies in both developed and emerging economies. Rising incidences of post-hemorrhagic and normal pressure hydrocephalus (NPH) among the elderly are also contributing to the market expansion
- North America dominated the hydrocephalus market with the largest revenue share of 39.4% in 2024, characterized by advanced neurosurgical infrastructure, high diagnosis rates, favorable reimbursement scenarios, and significant R&D investments by key players such as Medtronic and Integra LifeSciences. The U.S., in particular, is experiencing substantial growth due to strong healthcare accessibility and the availability of technologically advanced shunt devices
- Asia-Pacific is expected to be the fastest growing region in the hydrocephalus market during the forecast period, with a CAGR of 7.8%, driven by increasing birth rates, growing elderly populations, rising healthcare investments, and expanding access to diagnostic tools in countries such as India, China, and Japan
- The treatment segment dominated the hydrocephalus market with a market share of 62.7% in 2024, supported by the widespread use of ventriculoperitoneal (VP) shunting and newer procedures such as endoscopic third ventriculostomy (ETV). These interventions remain the cornerstone for managing cerebrospinal fluid buildup, with continuous innovations improving surgical outcomes, reducing risks, and driving adoption across pediatric and adult populations globally
